Loading
Total declarations
Companies
▲ Purchases (2 ops.)
▼ Sales (0 ops.)
Latest filing published 19 Mar 2025 for Zomedica Corp., €17k.
Filing timeline
BuySaleScott Jordan
Insider track record
Disclosed buys
2
Disclosed sells
0
Signal history
Closed purchases
Market purchases
2
Not enough history yet: 1 closed purchase, at least 2 are needed.
Purchases by company
Since each purchase
- +75.7%Entry US$0.07 · Close at T+365 US$0.12
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Scott Jordan: trading record in brief
Scott Jordan is a declared insider at 2 companies; the most frequent names are Salarius Pharmaceuticals, Inc. and Zomedica Corp. We count 2 filings; the first trade dates from 18 February 2020 and the latest from 17 March 2025.
Every open-market trade on record is a purchase: 2 purchases worth €26k, and no sale. Unlike grants, an open-market purchase is paid for by the insider, at the market price. So far in 2025, the count stands at 1 purchase and no sales.
The latest filing, published on 19 March 2025, reports an open-market purchase of €17k in Zomedica Corp. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Scott Jordan
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations2 total
300,000 shares@ US$0.062100.0% of flowCommon Stock, without par valueSEC:0001654954-25-003016:0
Canonical exit: 15 Jun 2025 (T+90)
11,300 shares@ US$0.90100.0% of flowCommon StockSEC:0001615219-20-000003:0
Canonical exit: 18 May 2020 (T+90)
2 of 2 declarations
